Evidence map›Paper›PMID 30721969›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2019

The Cortical Neuroimmune Regulator TANK Affects Emotional Processing and Enhances Alcohol Drinking: A Translational Study.

Christian P Müller, Congying Chu, Liya Qin, Chunyu Liu, Bing Xu, He Gao, Barbara Ruggeri, Saskia Hieber, Julia Schneider, Tianye Jia and 35 more

Abstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alcohol and the brain: from genes to circuits.Trends in neurosciences · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Christian P MüllerSection of Addiction Medicine, Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 6, Erlangen, Germany.
Congying ChuCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Liya QinBowles Center for Alcohol Studies, School of Medicine, University of North Carolina, Chapel Hill NC, USA.
Chunyu LiuThe Framingham Heart Study, 73 Mt Wayte Ave, Framingham MA, USA.
Bing XuCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
He GaoDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
Barbara RuggeriCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Saskia HieberSection of Addiction Medicine, Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 6, Erlangen, Germany.
Julia SchneiderInstitute for Biochemistry and Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Fahrstrasse 17, Erlangen, Germany.
Tianye JiaCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Nicole TayCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Shizuo AkiraLaboratory of Host Defense, World Premier International Immunology Frontiern Research Center, Research Institute for Microbial Diseases, Osaka University, 1-1 Yamadaoka, Suita, Osaka, Osaka, Japan.
Takashi SatohLaboratory of Host Defense, World Premier International Immunology Frontiern Research Center, Research Institute for Microbial Diseases, Osaka University, 1-1 Yamadaoka, Suita, Osaka, Osaka, Japan.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, Mannheim, Germany.
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, James's Street, Dublin, Ireland.
Uli BrombergUniversity Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, Hamburg, Germany.
Christian BüchelUniversity Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, Hamburg, Germany.
Erin Burke QuinlanCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Herta FlorDepartment of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, Mannheim, Germany.
Vincent FrouinNeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Hugh GaravanDepartments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.
Andreas HeinzDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.
Bernd IttermannPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany [ Physikalisch-Technische Bundesanstalt (PTB), Abbestr. 2-12, Berlin, Germany].
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud-University Paris Saclay, DIGITEO Labs, Rue Noetzlin, Gif sur Yvette, France.
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud-Paris Saclay, University Paris Descartes; and AP-HP, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, 47-83, boulevard de l'Hôpital, Paris, France.
Eric ArtigesInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud-University Paris Saclay, DIGITEO Labs, Gif sur Yvette; and Psychiatry Department, Orsay Hospital, Orsay, France.
Herve LemaitreInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris-Sud Medical School, France.
Frauke NeesDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, Mannheim, Germany.
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Tomáš PausRotman Research Institute, Baycrest and Departments of Psychology and Psychiatry, University of Toronto, 3560 Bathurst Street, Toronto, Ontario, Canada.
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5, Göttingen, Germany.
Sabina MillenetDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, Mannheim, Germany.
Juliane H FröhnerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Chemnitzer Str. 46a01187 Dresden, Germany.
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Chemnitzer Str. 46a01187 Dresden, Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.
Robert WhelanSchool of Psychology and Global Brain Health Institute, Aras an Phiarsaigh Trinity College Dublin, Dublin, Ireland.
Georgy BakalkinDivision of Biological Research on Drug Dependence, Department of Pharmaceutical, Biosciences, Uppsala University, Husargatan 3, Uppsala, Sweden.
Yun LiuKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education; Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai, P.R. China.
Sylvane DesrivièresCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.
Paul ElliottDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
Volker EulenburgInstitute for Biochemistry and Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Fahrstrasse 17, Erlangen, Germany.
Daniel LevyThe Framingham Heart Study, 73 Mt Wayte Ave, Framingham MA, USA.
Fulton CrewsBowles Center for Alcohol Studies, School of Medicine, University of North Carolina, Chapel Hill NC, USA.
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College De Crespigny Park, London, UK.

Funding

THE FRAMINGHAM HEART STUDYN01HC25195 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2007 to 2014
$83.8M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Department of HealthMedical Research Council MR/L01341X/1Medical Research Council MR/N000390/1Medical Research Council MR/N027558/1NHLBI NIH HHS N01HC25195NIBIB NIH HHS U54 EB020403
6 · The paper itself

Abstract

Alcohol abuse is a major public health problem worldwide. Understanding the molecular mechanisms that control regular drinking may help to reduce hazards of alcohol consumption. While immunological mechanisms have been related to alcohol drinking, most studies reported changes in immune function that are secondary to alcohol use. In this report, we analyse how the gene "TRAF family member-associated NF-κB activator" (TANK) affects alcohol drinking behavior. Based on our recent discovery in a large GWAS dataset that suggested an association of TANK, SNP rs197273, with alcohol drinking, we report that SNP rs197273 in TANK is associated both with gene expression (P = 1.16 × 10-19) and regional methylation (P = 5.90 × 10-25). A tank knock out mouse model suggests a role of TANK in alcohol drinking, anxiety-related behavior, as well as alcohol exposure induced activation of insular cortex NF-κB. Functional and structural neuroimaging studies among up to 1896 adolescents reveal that TANK is involved in the control of brain activity in areas of aversive interoceptive processing, including the insular cortex, but not in areas related to reinforcement, reward processing or impulsiveness. Our findings suggest that the cortical neuroimmune regulator TANK is associated with enhanced aversive emotional processing that better protects from the establishment of alcohol drinking behavior.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAgedAlcohol DrinkingAnimalsBrainCohort StudiesDNA MethylationEmotionsFemaleGenetic Association StudiesHumansMaleMice, 129 StrainMice, Inbred C57BLMice, KnockoutAdaptor Proteins, Signal TransducingNF-kappa BTANK protein, humanTank protein, mousealcoholanxietydrinkinginsular cortexNF-κBTANK

Identifiers

PMID30721969
PMCPMC6430980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.